Kim Seung-joo is the founder of SK Plasma. SK Plasma has raised $50M in total funding. Latest round: Growth. Backed by Indonesia Investment Authority.
Kim Seung-joo is the CEO of SK Plasma, a company that focuses on the growth and success of the plasma-derived biotherapy industry. SK Plasma spun off from SK Chemicals Life Science biz in 2015, aiming to improve competitiveness in the global plasma-derived medicinal products (PDMP) market. The company manufactures therapies like albumin and immunoglobulin for domestic and export markets, operating a plant in Andong, South Korea, and building another in Indonesia. SK Plasma is expanding its business through investments, collaborations with biotherapeutics companies, and R&D for innovative pipelines in rare and incurable diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library